Physician

Asok Dasgupta, M.D.

According to 2025 Medicare claims, Asok Dasgupta, M.D. (NPI: 1396855359) practices sleep medicine in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is MOUNT CARMEL HEALTHPROVIDERS TWO LLC (NPI: 1134154750; TIN: 311439334) and primary practice location at 43213-4440.

Dasgupta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 305 traditional Medicare patients, billed 497 HCPCS/CPT codes, and received $37,204 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,298 prescription claims across 238 beneficiaries totaling $568,420 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 4,358 claims. Open Payments data shows 7 records totaling $496. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $96,012 to $37,204. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments moved sharply higher in recent years, from $48,069 to $188,512.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	363	1,150	$96,012
2016	440	1,536	$117,150
2017	392	1,345	$103,020
2018	361	1,223	$91,720
2019	339	1,037	$81,208
2020	365	849	$72,713
2021	343	560	$46,469
2022	267	556	$41,157
2023	300	584	$43,016
2024	305	497	$37,204

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	176	949	$337,575
2016	170	1,097	$446,011
2017	171	1,196	$597,494
2018	180	1,276	$827,938
2019	169	1,265	$814,344
2020	211	1,309	$816,776
2021	240	1,335	$659,370
2022	208	1,064	$649,249
2023	228	1,163	$645,923
2024	238	1,298	$568,420

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	653	1,416	$46,300
2016	809	1,990	$59,085
2017	878	2,128	$69,673
2018	1,174	2,808	$95,294
2019	1,188	2,964	$103,261
2020	1,286	2,955	$133,065
2021	1,513	3,779	$175,475
2022	1,593	3,853	$188,537
2023	1,726	4,390	$222,642
2024	1,764	4,358	$217,084

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	36	36	$126
95811	Sleep study in sleep lab with continuous airway pressure (6 years or older)	39	39	$90
95810	Sleep study in sleep lab (6 years or older)	44	45	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	119	144	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	84	89	$62

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	107	5,970	$123,262
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	109	4,170	$86,891
Breo Ellipta	Fluticasone/Vilanterol	56	2,820	$35,875
Spiriva Respimat	Tiotropium Bromide	25	1,530	$25,888
Spiriva Handihaler	Tiotropium Bromide	22	1,560	$25,569

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	115	287	$24,917
A7030	Full face mask used with positive airway pressure device, each	N	116	279	$22,541
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	29	$22,097
A7032	Cushion for use on nasal mask interface, replacement only, each	N	102	213	$19,698
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	164	371	$18,059

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$496	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Asok Dasgupta, M.D.?

Tedicare shows public-source Medicare data for Asok Dasgupta, M.D. (NPI 1396855359), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Asok Dasgupta, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Asok Dasgupta, M.D.?

Asok Dasgupta, M.D. is linked to MOUNT CARMEL HEALTHPROVIDERS TWO LLC (billing NPI 1134154750) in the available physician profile data.

Does Asok Dasgupta, M.D. have Open Payments data?

Asok Dasgupta, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.